Tags

Type your tag names separated by a space and hit enter

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.
Emerg Infect Dis. 2015 Jan; 21(1):115-8.EI

Abstract

In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25536336

Citation

Gamougam, Kadidja, et al. "Continuing Effectiveness of Serogroup a Meningococcal Conjugate Vaccine, Chad, 2013." Emerging Infectious Diseases, vol. 21, no. 1, 2015, pp. 115-8.
Gamougam K, Daugla DM, Toralta J, et al. Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. Emerging Infect Dis. 2015;21(1):115-8.
Gamougam, K., Daugla, D. M., Toralta, J., Ngadoua, C., Fermon, F., Page, A. L., Djingarey, M. H., Caugant, D. A., Manigart, O., Trotter, C. L., Stuart, J. M., & Greenwood, B. M. (2015). Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. Emerging Infectious Diseases, 21(1), 115-8. https://doi.org/10.3201/eid2101.140256
Gamougam K, et al. Continuing Effectiveness of Serogroup a Meningococcal Conjugate Vaccine, Chad, 2013. Emerging Infect Dis. 2015;21(1):115-8. PubMed PMID: 25536336.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. AU - Gamougam,Kadidja, AU - Daugla,Doumagoum M, AU - Toralta,Jacques, AU - Ngadoua,Cyriaque, AU - Fermon,Florence, AU - Page,Anne-Laure, AU - Djingarey,Mamoudou H, AU - Caugant,Dominique A, AU - Manigart,Olivier, AU - Trotter,Caroline L, AU - Stuart,James M, AU - Greenwood,Brian M, PY - 2014/12/24/entrez PY - 2014/12/24/pubmed PY - 2015/9/4/medline SP - 115 EP - 8 JF - Emerging infectious diseases JO - Emerging Infect. Dis. VL - 21 IS - 1 N2 - In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted. SN - 1080-6059 UR - https://www.unboundmedicine.com/medline/citation/25536336/full_citation L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25536336/ DB - PRIME DP - Unbound Medicine ER -